Prana drug reduces cognitive impairment
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2013
Singapore: Prana Biotechnology announced the upcoming presentation of new data demonstrating the ability of PBT2 to redu...Read more
Aussie firm's new breakthrough in bladder cancer
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2015
Singapore: Australia-based startup company Sienna Cancer Diagnostics, has inked a pact with an American pathology compan...Read more
Brain cancer drug may be effective in melanoma treatment
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Dec, 2014
Singapore: Australia based Novogen's lead candidate, TRXE-009, developed for the treatment of brain cancers, has shown t...Read more
Australia to review kids' asthma drugs
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 20 Feb, 2013
Singapore: Department of Health and Ageing under the Australian Government's National Medicines Policy framework, is con...Read more
Aus minister launches code book for directors
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2013
Singapore: Australia's Minister for Technology, Mr Gordon Rich-Phillips launched the two-day Australia Biotech Invest 20...Read more
Aussie firm initiates bronchitis drug trial for smokers
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: Australia-based clinical-stage drug development company, Invion, initiated and commenced patient enrolment in...Read more
Ascend to begin PhII trial for skin cancer
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2014
Singapore: Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, plans to begin a Phase 2 clinical trial o...Read more
Cellmid midkine antibodies reduce kidney damage
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Jan, 2013
Singapore: Cellmid completed its first in-life diabetic nephropathy study with two of its anti-midkine antibodies (MK-Ab...Read more
AusBiotech recognizes bioscience innovators
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Nov, 2014
Singapore: Australia has acknowledged its bioscience innovators and companies through an industry excellence awards orga...Read more
New anti-typhoid gene discovered
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Nov, 2014
Singapore: Researchers have found a new variant of a gene that can confer five-fold protection against typhoid fever. Th...Read more
'Medical device regulatory is complex'
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Nov, 2014
Singapore: Medical device industry is a complex one and even more complex is the regulatory landscape of the sector, ech...Read more
Danish firm, Aussie instiute to co-develop pathological drugs
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2013
Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has f...Read more
Agilent opens $25 mn spectroscopy center in Aus
Australia | News | By BioSpectrum Bureau | 0 Comment | 30 Aug, 2013
Singapore: Agilent Technologies has launched Spectroscopy Technology Innovation Center in Mulgrave, Australia, with an i...Read more
Novogen's chemotherapeutic agent set to enter human trial in 2015
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Dec, 2014
Singapore: Cantrixil, a first-in-class experimental chemotherapeutic, developed by Australia/US-based biotech firm Novog...Read more
Auspherix raises $1 mn for antibiotics
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2014
Singapore: Auspherix, an early stage anti-infectives company developing novel antibiotics to treat resistant bacterial d...Read more
Clinuvel's subisidiary develops drug candidate for vitiligo
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 May, 2015
Singapore: Australia and Switzerland based Clinuvel Pharmaceuticals' Singapore subsidiary Vallaurix has successfully com...Read more
Aus invests $1mn in antibiotics start-up Auspherix
Australia | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2013
Singapore: Australia's Medical Research Commercialisation Fund (MRCF) has invested around $1 million in an early stage a...Read more
BioDiem's live attenuated influenza virus give positive results
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2012
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has achieved successful result ...Read more